Related references
Note: Only part of the references are listed.Safety and Survival Rates Associated With Ablative Stereotactic Radiotherapy for Patients With Oligometastatic Cancer A Systematic Review and Meta-analysis
Eric J. Lehrer et al.
JAMA ONCOLOGY (2021)
Evaluation of Safety of Stereotactic Body Radiotherapy for the Treatment of Patients With Multiple Metastases Findings From the NRG-BR001 Phase 1 Trial
Steve Chmura et al.
JAMA ONCOLOGY (2021)
Outcomes of extra-cranial stereotactic body radiotherapy for metastatic breast cancer: Treatment indication matters
Hendrick Tan et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Long-term disease control and survival observed after stereotactic ablative body radiotherapy for oligometastatic breast cancer
N. Ari Wijetunga et al.
CANCER MEDICINE (2021)
Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non-Small-Cell Lung Cancer
Kyle G. Mitchell et al.
CLINICAL LUNG CANCER (2020)
Stereotactic ablative body radiotherapy (SABR) for bone only oligometastatic breast cancer: A prospective clinical trial
Steven David et al.
BREAST (2020)
Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation
Matthias Guckenberger et al.
LANCET ONCOLOGY (2020)
Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer
Fabian Weykamp et al.
FRONTIERS IN ONCOLOGY (2020)
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
David A. Palma et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Single-fraction stereotactic ablative body radiotherapy for sternal metastases in oligometastatic breast cancer: Technique and single institution experience
Michelle P. Li et al.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY (2020)
Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document
Yolande Lievens et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade
Michael T. Milano et al.
RADIOTHERAPY AND ONCOLOGY (2019)
The Dandelion Dilemma Revisited for Oligoprogression: Treat the Whole Lawn or Weed Selectively?
P. H. Patel et al.
CLINICAL ONCOLOGY (2019)
Salvage radiotherapy for second oligo-recurrence in patients with breast cancer
Mari Miyata et al.
JOURNAL OF RADIATION RESEARCH (2018)
Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
Kathleen A. Cronin et al.
CANCER (2018)
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial
Shankar Siva et al.
EUROPEAN UROLOGY (2018)
Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial
Piet Ost et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial
Marco Trovo et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Treatment outcomes of breast cancer liver metastasis treated with stereotactic body radiotherapy
Cem Onal et al.
BREAST (2018)
Phase II trial on SBRT for unresectable liver metastases: long-term outcome and prognostic factors of survival after 5 years of follow-up
Marta Scorsetti et al.
RADIATION ONCOLOGY (2018)
Ablative Therapies in Metastatic Breast Cancer: A Systematic Review
Michael Jonathan Kucharczyk et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer
Marta Scorsetti et al.
BREAST (2016)
Clinical and molecular markers of long-term survival after oligometastasis-directed stereotactic body radiotherapy (SBRT)
Anthony C. Wong et al.
CANCER (2016)
Stereotactic body radiotherapy for oligometastatic breast cancer: a new standard of care, or a medical reversal in waiting?
Michael W. Drazer et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2016)
Prognostic factors in breast cancer with extracranial oligometastases and the appropriate role of radiation therapy
Gyu Sang Yoo et al.
RADIATION ONCOLOGY JOURNAL (2015)
The Role of Surgery and Ablative Radiotherapy in Oligometastatic Breast Cancer
Joseph K. Salama et al.
SEMINARS IN ONCOLOGY (2014)
Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review
Tadashi Kobayashi et al.
BREAST CANCER (2012)
Oligometastatic breast cancer treated with curative-intent stereotactic body radiation therapy
Michael T. Milano et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
A prospective pilot study of curative-intent stereotactic body radiation therapy in patients with 5 or fewer oligometastatic lesions
Michael T. Milano et al.
CANCER (2008)
Gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment
Kathy S. Albain et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Share Paper
